Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kazazic, M.
Right arrow Articles by Fimland, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kazazic, M.
Right arrow Articles by Fimland, G.
Agricola
Right arrow Articles by Kazazic, M.
Right arrow Articles by Fimland, G.
Microbiology (2002), 148, 2019-2027.
© 2002 Society for General Microbiology


Research Paper

Mutational analysis of the role of charged residues in target-cell binding, potency and specificity of the pediocin-like bacteriocin sakacin P

Maja Kazazic1, Jon Nissen-Meyer1 and Gunnar Fimland1

Department of Biochemistry, University of Oslo, Post Box 1041, Blindern, 0316 Oslo, Norway1

Author for correspondence: Gunnar Fimland. Tel: +47 22 85 66 32 or +47 22 85 73 51. Fax: +47 22 85 44 43. e-mail: gunnar.fimland{at}biokjemi.uio.no

The significance of charged residues for the target-cell binding, potency and specificity of pediocin-like bacteriocins has been studied by site-directed mutagenesis of sakacin P. Most of the charged residues are located in the N-terminal half, which is thought to mediate the initial binding of these bacteriocins to target cells through electrostatic interaction. All the mutated peptides in which the net positive charge was reduced by one (by replacing a charged residue with threonine) exhibited reduced binding to target cells and a 2–15-fold reduction in potency. The least deleterious of these mutations was the removal of the positive charge in position 8 (H8T). This mutation was, in fact, less deleterious than the conservative His to Lys mutation, indicating that the positive charge in position 8 per se is not of major importance. Somewhat more deleterious was the removal of positive charges at the N- and C-terminal ends (K1T, K43T). Most deleterious was the elimination of the positive charge at positions 11 and (but to a lesser extent) 12, demonstrating the importance of the cationic patch in the middle of the N-terminal half of pediocin-like bacteriocins. Mutated peptides in which the net positive charge was increased by one were also constructed. Some of these exhibited increased cell binding and a potency that was the same as (44K, i.e. an extra positive charge at the C-terminus), or somewhat greater (T20K) than, that of sakacin P, whereas others (0K, i.e. an extra positive charge at the N-terminus) had reduced potency. Sakacin P contains only one negatively charged residue (Asp17). This negative charge and its orientation in space were crucial for activity, since the Asp to Asn mutation and (especially) the conservative Asp to Glu mutation were deleterious. Mutations that made the peptide less cationic had, overall, less effect on the potency toward the Carnobacterium piscicola strain than on the potency toward the three other strains tested, whereas the opposite was the case for mutations that made the peptide more cationic. Thus, charged residues in the N-terminal half may – apparently via the initial electrostatic binding of the bacteriocin to target cells – influence the target-cell specificity.

Keywords: antimicrobial peptides, mutagenesis, lactic acid bacteria




This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
M. Sanchez-Hidalgo, M. Martinez-Bueno, A. M Fernandez-Escamilla, E. Valdivia, L. Serrano, and M. Maqueda
Effect of replacing glutamic residues upon the biological activity and stability of the circular enterocin AS-48
J. Antimicrob. Chemother., June 1, 2008; 61(6): 1256 - 1265.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
T. Tominaga and Y. Hatakeyama
Development of Innovative Pediocin PA-1 by DNA Shuffling among Class IIa Bacteriocins
Appl. Envir. Microbiol., August 15, 2007; 73(16): 5292 - 5299.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
D. Drider, G. Fimland, Y. Hechard, L. M. McMullen, and H. Prevost
The Continuing Story of Class IIa Bacteriocins
Microbiol. Mol. Biol. Rev., June 1, 2006; 70(2): 564 - 582.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
T. Tominaga and Y. Hatakeyama
Determination of Essential and Variable Residues in Pediocin PA-1 by NNK Scanning
Appl. Envir. Microbiol., February 1, 2006; 72(2): 1141 - 1147.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
D. A. Brede, T. Faye, M. P. Stierli, G. Dasen, A. Theiler, I. F. Nes, L. Meile, and H. Holo
Heterologous Production of Antimicrobial Peptides in Propionibacterium freudenreichii
Appl. Envir. Microbiol., December 1, 2005; 71(12): 8077 - 8084.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Johnsen, B. Dalhus, I. Leiros, and J. Nissen-Meyer
1.6-A Crystal Structure of EntA-im: A BACTERIAL IMMUNITY PROTEIN CONFERRING IMMUNITY TO THE ANTIMICROBIAL ACTIVITY OF THE PEDIOCIN-LIKE BACTERIOCIN ENTEROCIN A
J. Biol. Chem., May 13, 2005; 280(19): 19045 - 19050.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Johnsen, G. Fimland, and J. Nissen-Meyer
The C-terminal Domain of Pediocin-like Antimicrobial Peptides (Class IIa Bacteriocins) Is Involved in Specific Recognition of the C-terminal Part of Cognate Immunity Proteins and in Determining the Antimicrobial Spectrum
J. Biol. Chem., March 11, 2005; 280(10): 9243 - 9250.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
D. Morisset, J.-M. Berjeaud, D. Marion, C. Lacombe, and J. Frere
Mutational Analysis of Mesentericin Y105, an Anti-Listeria Bacteriocin, for Determination of Impact on Bactericidal Activity, In Vitro Secondary Structure, and Membrane Interaction
Appl. Envir. Microbiol., August 1, 2004; 70(8): 4672 - 4680.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2002 Society for General Microbiology.